in this issue
EnviroTech :: Biotech
Amgen and Astellas form biopharmaceuticals joint venture in Japan
9:28 AM MDT | May 29, 2013 | Natasha Alperowicz
Amgen (Thousand Oaks, CA), the world's largest independent biotechnology company; and Astellas Pharma (Tokyo), a leading pharmaceutical company, have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese patients, the companies announced today. The alliance leverages the complementary capabilities of both companies through an innovative business model that combines Amgen's pipeline candidates with Astellas's knowledge of Japanese patient and physician needs, long-term commercial and regulatory...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee